Product information

Current status:

Cancelled Post Market

Current status date:

1998-12-15

Original market date: ^{See footnote 1}

1994-12-31

Product name:

WYAMINE SULFATE INJECTION LIQ 30MG/ML

DIN:

02043769 Electronic product monograph is not available

Company:

WYETH-AYERST CANADA INC.
1025 Marcel Laurin Blvd.
St. Laurent
Quebec
Canada H4R 1J6

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous ,  Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

12:12.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

C01CA11 MEPHENTERMINE

Active ingredient group (AIG) number:^{See footnote5}

0107583001